Description
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with bidding open from May 8 to May 14, 2026 and settlement on May 21, 2026.
Summary
ICCL (Indian Clearing Corporation Ltd.) has published the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited. The buyback window runs from May 8 to May 14, 2026, under Settlement No. 2026049, with final settlement on May 21, 2026.
Key Points
- Buyback bidding window: May 8, 2026 to May 14, 2026
- Settlement number: 2026049
- Obligation download date: May 20, 2026
- Settlement date: May 21, 2026
- Demat shares must be delivered exclusively via the Early Pay-in of Shares mechanism (available through both CDSL and NSDL)
- Market Type “(Buyback)” and Settlement No. 2026049 must be used in the depository system
- Members/Custodians are NOT required to upload any EPN file for early pay-in
- CDSL & NSDL early pay-in securities will be earmarked/blocked in client accounts under the requisite market type and settlement number
Regulatory Changes
No new regulatory changes introduced. Members/Custodians are directed to refer to existing Notice No. 20200528-32 (dated May 28, 2020) regarding settlement as per Revised Guidelines of Mechanism for Acquisition of Shares through Stock Exchange.
Compliance Requirements
- Members and Custodians must ensure early pay-in of securities is reflected in BSE/ICCL systems before the prescribed timelines for accepting/confirming bids on the BSE OTB platform
- Early pay-in must be completed sufficiently in advance of the closure of the BSE OTB Bidding window (for members placing bids) and the Confirmation window (for Custodians confirming bids)
- Use Market Type “(Buyback)” and Settlement No. 2026049 when processing in the depository system
- Members should refer to the
MBRSTD_OTB_CM_mmm_SettNofile for client-wise Stamp Duty charges
Important Dates
| Event | Date |
|---|---|
| Bid Start Date | May 8, 2026 |
| Bid End Date | May 14, 2026 |
| Obligation Download | May 20, 2026 |
| Settlement Date | May 21, 2026 |
Impact Assessment
This notice is operationally significant for Members and Custodians participating in the Jagsonpal Pharmaceuticals Limited buyback. The early pay-in requirement via depository mechanisms (CDSL/NSDL) means participants must plan share delivery well ahead of bid window closure. The absence of an EPN file upload requirement simplifies the process. Broader market impact is limited to participants directly involved in this specific buyback offer. For queries, ICCL Help Desk can be reached at 022-69158590/45720490/45720690 or iccl.helpdesk@icclindia.com.
Impact Justification
Operational settlement notice relevant to members and custodians participating in Jagsonpal Pharmaceuticals buyback; limited broader market impact but critical for direct participants.